| Overview |
| bsm-33102M-PE-Cy5 |
| CK18 Monoclonal Antibody, PE-Cy5 Conjugated |
| WB |
| Human, Mouse |
| Specifications |
| PE-Cy5 |
| Mouse |
| KLH conjugated synthetic peptide derived from human CK18 |
| Monoclonal |
| #REF! |
| IgG |
| 1ug/ul |
| Purified by Protein G. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 3875 |
| P05783 |
| Cytoplasm, Cytomembrane |
| Cell proliferation inducing gene 46 protein; Cell proliferation inducing protein 46; CK 18; CK18; CYK18; Cytokeratin 18; Cytokeratin endo B; Cytokeratin18; Keratin 18; Keratin D; Keratin type I cytoskeletal 18; Kerd; KRT18. |
| When phosphorylated, plays a role in filament reorganization. Involved in the delivery of mutated CFTR to the plasma membrane. Involved in the uptake of thrombin-antithrombin complexes by hepatic cells (By similarity). Together with KRT8, is involved in interleukin-6 (IL-6)-mediated barrier protection. |
| Application Dilution |
| WB |
1:300-5000 |